Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3498-3505

  Cuthbert, Jennifer A ^a   Lipsky, Peter E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MEVALONIC ACID; MEVINOLIN; RAS PROTEIN; STEROL;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; GENE LOCATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOBLASTOID CELL LINE; LYMPHOMA CELL LINE; ONCOGENE RAS; PRENYLATION; PRIORITY JOURNAL;

ACYL COENZYME A; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL MEMBRANE; ENZYME INHIBITORS; HUMANS; LEUKEMIA; LOVASTATIN; LYMPHOMA; MEVALONIC ACID; NEOPLASM PROTEINS; RAS PROTEINS; TUMOR CELLS, CULTURED;

EID: 0030749232     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
2. Bos, J. L. The ras gene family and human carcinogenesis. Mutat. Res.,. 195: 255-271, 1988.
3. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
4. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
5. Willumsen, B. M., Norris, K., Papageorge, A. G., Hubbert, N. L., and Lowy, D. R. Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J., 3: 2581-2585, 1984.
6. Jackson, J. H., Cochrane, C. G., Bourne, J. R., Solski, P. A., Buss, J. E., and Der, C. J. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc. Natl. Acad. Sci. USA, 87: 3042-3046, 1990.
7. ras to the plasma membrane. Cell, 63: 133-139, 1990.
8. Kohl, N. E., Mosser, S. D., deSolms, J., Giuliani, E. A., Pompliano, D. L., Graham, S. L., Smith, R. L., Scolnick, B. M., Oliff, A., and Gibbs, J. B. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science (Washington DC), 260: 1934-1937, 1993.
9. James, G. L., Goldstein, J. L., Brown, M. S., Rawson, T. E., Somers, T. C., McDowell, R. S., Crowley, C. W., Lucas, B. K., Levinson, A. D., and Marsters, J. C., Jr. Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells, Science (Washington DC), 260: 1937-1942, 1993.
10. Kohl, N. E., Wilson, F. R., Mosser, S. D., Giuliani, E., deSolms, S. J., Conner, M. W., Anthony, N. J., Holtz, W. J., Gomez, R. P., Lee, T. J., Smith, R. L., Graham, S. L., Hartman, G. D., Gibbs, J. B., and Oliff, A. Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc. Natl. Acad. Sci. USA, 91: 9141-9145, 1994.
11. Kohl, N. E., Omer, C. A., Conner, M. W., Anthony, N. J., Davide, J. P., deSolms, S. J., Giuliani, E. A., Gomez, R. P., Graham, S. L., Hamilton, K., Handt, L. K., Hartman, G. D., Koblan, K. S., Kral, A. M., Miller, P. J., Mosser, S. D., O'Neill, T. J., Rands, E., Schaber, M. D., Gibbs, J. B., and Oliff, A. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat. Med., 1: 792-797, 1995.
12. Hancock, J. F., Magee, A. I., Childs, J. E., and Marshall, C. J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57: 1167-1177, 1989.
13. Schafer, W. R., Kim, R., Sterne, R., Thorner, J., Kim, S. H., and Rine, J. Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science (Washington DC), 245: 379-385, 1989.
14. Casey, P. J., Solski, P. A., Der, C. J., and Buss, J. E. p21ras is modified by a farnesyl isoprenoid. Proc. Natl. Acad. Sci. USA, 86: 8323-8327, 1989.
15. Goldstein, J. L., and Brown, M. S. Regulation of the mevalonate pathway. Nature (Lond.), 343: 425-430, 1990.
16. Nave, J. F., d'Orchymont, H., Ducep, J. B., Piriou, F., and Jung, M. J. Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate. Biochem. J., 227: 247-254, 1985.
17. Reardon, J. E., and Abeles, R. H. Inhibition of cholesterol biosynthesis by fluorinated mevalonate analogues. Biochemistry, 26: 4717-4722, 1987.
18. Cuthbert, J. A., and Lipsky, P. E. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation. J. Biol. Chem., 265: 18568-18575, 1990.
19. Cuthbert, J. A., and Lipsky, P. E. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism. Cancer Res., 55: 1732-1740, 1995.
20. Cuthbert, J. A., and Lipsky, P. E. Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates. J. Biol. Chem., 266: 17966-17971, 1991.
21. Hurley, J. N., Fu, S. M., Kunkel, H. G., McKenna, G., and Scharff, M. D. Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis. Proc. Natl. Acad. Sci. USA, 75: 5706-5710, 1978.
22. Nicklas, J. A., Miyachi, Y., Taurog, J. D., Wee, S. L., Chen, L. K., Grumet, F. C., and Bach, F. H. HLA loss variants of a B27 + lymphoblastoid cell line: genetic and cellular characterization. Hum. Immunol., 11: 19-30, 1984.
23. Quistad, G. B., Cerf, D. C., Schooley, D. A., and Staal, G. B. Fluoromevalonate: an inhibitor of insect juvenile hormone biosynthesis. Pr. Nauk. Inst. Chem. Org. Fiz. Politech. Wroclaw., 22: 163-168, 1981.
24. Cuthbert, J. A., and Lipsky, P. E. Provision of cholesterol to lymphocytes by high density and low density lipoproteins. Requirement for low density lipoprotein recep tors. J. Biol. Chem., 262: 7808-7818, 1987.
25. Brown, M. S., Dana, S. E., and Goldstein, J. L. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. J. Biol. Chem., 249: 789-796, 1974.
26. Panini, S. R., Schnitzer-Polokoff, R., Spencer, T. A., and Sinensky, M. Sterol-independent regulation of 3-hydroxy-3-methylglutaryl-CoA reductase by mevalonate in Chinese hamster ovary cells. J. Biol. Chem., 264: 11044-11052, 1989.
27. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
28. Mumby, S. M., Casey, P. J., Gilman, A. G., Gutowski, S., and Sternweis, P. C. G protein γ subunits contain a 20-carbon isoprenoid. Proc. Natl. Acad. Sci. USA, 87: 5873-5877, 1990.
29. Niman, H. L. Human oncogene-related proteins in urine during pregnancy and neoplasia. Clin. Lab. Med., 6: 181-196, 1986.
30. ras in normal and malignant tissues: lack of association with proliferation and malignancy. Proc. Natl. Acad. Sci. USA, 84: 3234-3238, 1987.
31. Watson, J. A., Havel, C. M., Lobos, D. V., Baker, F. C., and Morrow, C. J. Isoprenoid synthesis in isolated embryonic drosophila cells. Sterol-independent regulatory signal molecule is distal to isopentenyl 1-pyrophosphates. J. Biol. Chem., 260: 14083-14091, 1985.
32. Lerner, E. C., Qian, Y. M., Blaskovich, M. A., Fossum, R. D., Vogt, A., Sun, J. Z., Cox, A. D., Der, C. J., Hamilton, A. D., and Sebti, S. M. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem., 270: 26802-26806, 1995.
33. Miyake, M., Mizutani, S., Koide, H., and Kaziro, Y. Unfarnesylated transforming Ras mutant inhibits the Ras-signaling pathway by forming a stable Ras-Raf complex in the cytosol. FEBS Lett., 378: 15-18, 1996.
34. Dimster-Denk, D., Schafer, W. R., and Rine, J. Control of RAS mRNA level by the mevalonate pathway. Mol. Biol. Cell, 6: 59-70, 1995.